Master Insight Coach, John Strasser, Gives Thoughts on the New FDA Alzheimer's Drug Approved in Nearly 20 Years
The US Food and Drug Administration on Monday approved the use of the experimental drug aducanumab for early phases of Alzheimer's disease -- despite an FDA
Source: einnews.com